Sort
40,608 grants matching “prostate cancer”
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER
$668,484Kathryn L Taylor · Georgetown University · R01 · FY2014 · CA
Control of the immune response for cancer vaccine development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas
$668,427Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
$668,427David Basanta Gutierrez · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
$668,422Simon Andrew Gayther · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Genetic Aspects Of Viral Oncogenesis In Wild Mouse Species
$668,391Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
$668,323Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
$668,323Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Improving Cancer Outcomes for African-Americans
$668,211New Hanover Regional Medical Center · U56 · FY2005 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$668,089Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy
$668,068Michael C Haffner · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Biological Functions of Chromosomal Proteins
$668,049Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Genetic Susceptibility And The Environment In Cancer Risk
$668,041Jack A Taylor · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$668,014Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
$667,924Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2023 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$667,915Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
$667,617Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Research Program
$667,602Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2021 · CA
Application of MAGNet Tools to Gene Regulatory Networks in Cancer
$667,585Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Evaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
$667,582Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Physician Assistance Technology in Image-guided Robotic Intervention of Prostate
$667,541Nobuhiko Hata · Brigham And Women'S Hospital · R01 · FY2022 · EB
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis
$667,475Alan Pollack · University Of Miami School Of Medicine · R01 · FY2014 · CA
Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging
$667,466Sanjiv S Gambhir · Stanford University · U54 · FY2009 · CA
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
$667,356Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2022 · CA